Clinical Trials Logo
  1. Home
  2. Lichen Planus, Oral
  3. NCT02276573
  4. Details
NCT02276573 Clinical Trial

Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus

Lichen Planus, Oral Clinical Trial

— LICHENVIR  

Official title:
Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT02276573
Other study ID # 14-AOI-02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 30, 2015
Est. completion date March 10, 2016

Study information
Verified date November 2023
Source Centre Hospitalier Universitaire de Nice
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Oral lichen planus (OLP) is a chronic inflammatory and relapsing. The average prevalence is 1 to 4%. The clinics forms are many and symptoms are varied. The erosive form, painful and debilitating is characterized by erosive areas, ulcerated on an erythematous base with or without a keratinocyte lichenien network. The literature data moving towards an autoimmune origin, but the pathophysiological mechanisms of OLP remain unknown. This project represents the first part of a comprehensive project to examine the oral pathogenesis of different viruses (Herpes and papillomavirus HPV) and centered on Epstein-Barr Virus (EBV).

Recruitment information / eligibility
Status Completed
Enrollment 13
Est. completion date March 10, 2016
Est. primary completion date March 10, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient = 18 years - Clinical and/or histological diagnosis of erosive or atrophic OLP - No signs of severe dysplasia at the sampling Exclusion Criteria: o immunosuppressive or anti-inflammatory therapies at the inclusion

Study Design

Related Conditions & MeSH terms

Intervention

Biological:
• buccal cavity sample

Locations
Country Name City State
France Hôpital saint Roch Nice

Sponsors (1)
Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Measure of level of EBV nucleic acids day 1
See also
  Status Clinical Trial Phase
Recruiting NCT03320460 - Photobiomodulation in Oral Lichen Planus N/A
Recruiting NCT06158113 - Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study Phase 2
Completed NCT03687437 - Lichen Planus and Mean Platelet Volum
Completed NCT00130572 - Efficacy of Elidel Cream on Erosive Oral Lichen Planus Phase 3
Completed NCT04673916 - Treatment Protocols for Patients With Symptomatic Oral Lichen Planus N/A
Not yet recruiting NCT06362005 - The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus Phase 4
Completed NCT00133107 - Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus N/A
Completed NCT00102557 - Hydroxychloroquine vs. Clobetasol Rinse to Treat Oral Lichen Planus Phase 2
Completed NCT04718311 - Study on Treatment for Patients With Symptomatic Oral Lichen Planus N/A
Recruiting NCT05330572 - Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
Completed NCT00656214 - Treatmant of Oral Lichen Planus With Lycopene Phase 2
Completed NCT04976673 - Comparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen Planus Phase 2
Completed NCT00746772 - Efficacy of Purslane in Treatment of Oral Lichen Planus Phase 2